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Human polyomavirus JC (JCV) infects 80% of the population worldwide. Primary infection, typically occurring during childhood, is
asymptomatic in immunocompetent individuals and results in lifelong latency and persistent infection. However, among the severely
immunocompromised, JCV may cause a fatal demyelinating disease, progressive multifocal leukoencephalopathy (PML). Virus–host interactions
influencing persistence and pathogenicity are not well understood, although significant regulation of JCVactivity is thought to occur at the level of
transcription. Regulation of the JCV early and late promoters during the lytic cycle is a complex event that requires participation of both viral and
cellular factors. We have used cDNAmicroarray technology to analyze global alterations in gene expression in JCV-permissive primary human fetal
glial cells (PHFG). Expression of more than 400 cellular genes was altered, including many that influence cell proliferation, cell communication and
interferon (IFN)-mediated host defense responses. Genes in the latter category included signal transducer and activator of transcription 1 (STAT1),
interferon stimulating gene 56 (ISG56), myxovirus resistance 1 (MxA), 2V5V-oligoadenylate synthetase (OAS), and cig5. The expression of these
genes was further confirmed in JCV-infected PHFG cells and the human glioblastoma cell line U87MG to ensure the specificity of JCV in inducing
this strong antiviral response. Results obtained by real-time RT-PCR and Western blot analyses supported the microarray data and provide temporal
information related to virus-induced changes in the IFN response pathway. Our data indicate that the induction of an antiviral response may be one of
the cellular factors regulating/controlling JCV replication in immunocompetent hosts and therefore constraining the development of PML.
D 2005 Elsevier Inc. All rights reserved.Keywords: Polyomavirus; JCV; PML; Interferon stimulating genes; cig5; MxA; U87MG; Primary human fetal glial cells; Transfection; Infection; Microarray; Real-
time PCR; Copy numbers; Chimeras; JCV-SV40 chimera; Mad1/SVEDeltaIntroduction
JC virus (JCV) is the causative agent of progressivemultifocal
leukoencephalopathy (PML), a fatal demyelinating neurodegen-
erative disease, occurring in individuals severely immunocom-
promised as the result of AIDS, advanced malignancy or organ
transplantation (Berger, 2003a; Berger andMajor, 1999). Prior to
1980, PML was a rare disease, but, in the AIDS era, 3–5% of
AIDS patients are diagnosed with PML (Antinori et al., 2001;
Berger, 2003b; Snider et al., 1983). In immunocompetent0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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viruria is common. After primary infection, JCV may persist in
the kidney and possibly at other sites in the human body (Dorries,
2001). Reactivation occurs under conditions of impaired
immunocompetence and results in the destruction of oligoden-
drocytes, the myelin-forming cells, for which JCV has a strong
tropism (Padgett and Walker, 1973; Padgett and Walker, 1983).
The JCV genome is comprised of a double-stranded circular
DNAdivided into early and late gene-coding regions betweenwhich
lies a regulatory region containing the viral promoter–enhancer
sequences and the origin of replication (Frisque, 1983). Large T
antigen, the main viral regulatory protein, specifies several activities
through which the virus commandeers the cellular metabolic
machinery for production of virions. Glial-specific expression of T
antigen, via the early viral promoter, contributes to JCV’s neurotropic6) 457 – 467
www.e
Fig. 1. Replication of JCV DNA in transfected PHFG cells. (A) DNA was
extracted on days 3, 5, 10, and 15 following transfection, and JCV DNA
replication was measured using a modified DpnI replication assay (Ziegler e
al., 2004). After digestion of the DNA with DpnI and EcoRI, DNA fragments
were separated by gel electrophoresis, transferred to a nylon membrane and
hybridized with linear full-length 32P-labeled JCV DNA. The membrane was
exposed to a phosphor screen, and the signal was detected by scanning the
screen with the Molecular Imager FX system (Bio-Rad). The 5.1-kb band
represents the replicated JCV DNA. (B) RNA was extracted on days 3, 5, 10
and 15 following transfection, and cDNA was synthesized from 1 Ag of tota
RNA using Superscript II reverse transcriptase (Invitrogen). One microliter o
cDNA was used in all PCR reactions, except for GAPDH, in which 0.5 AL o
cDNAwas used. PCR was conducted using primers specific for genes encoding
T antigen, agnoprotein and VP1.
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proteins are synthesized from alternatively spliced mRNAs,
transported to the nucleus and assembled into progeny virions. In
addition, the late transcripts also encode agnoprotein, which
influences various stages of the viral lytic cycle, including expression
and translation of viral late proteins and viral replication via physical
interactions with T antigen (Endo et al., 2003; Safak et al., 2002).
In vitro, JCV has a highly restricted host range, making
pathogenesis studies challenging. Primary human fetal glial
(PHFG), a heterogeneous population of glial cells, remains the
most permissive system in vitro to propagate JCV, although
transformed derivatives of these cells also support moderate to
efficient production of infectious virions (Major et al., 1985;
Mandl et al., 1987). Our laboratory has recently shown that the
human glial cell line (U87MG) derived from human glioblas-
toma can efficiently support JCV replication and virion
production (P. Ananthula et al., unpublished observations).
Infection of cells by viruses typically elicits a potent and
dramatic shift in the transcriptional activity of host cellular
genes. These changes have been shaped by co-evolution of the
host and pathogen and mainly reflect the strategies developed by
the virus to facilitate its own survival. The hallmark of the host
response is the expression of interferons (IFN), best known for
their antiviral properties (Samuel, 2001). As a countermeasure to
this response, many viruses encode proteins that interfere with
the products of IFN-stimulated genes (ISG). A better under-
standing of viral–host interactions will be central to our ability
to control the pathogenic potential of JCV in its human host.
Since modulation of host cell gene expression by JCV is likely to
be important to altering the cellular environment to facilitate
viral replication, the primary objective of this study was to
identify cellular responses that are specifically regulated by JCV.
We employed cDNA microarray technology as a means to
simultaneously compare expression profiles of a large number of
host genes in PHFG cells following transfection with a full-
length infectious clone of JCV(Mad1). The host response to JCV
was analyzed by hybridizing mRNA extracted from JCV- and
mock-transfected populations of cells to Affymetrix gene chips.
Our results indicate significant induction of several ISG,
including signal transducer and activator of transcription1
(STAT1), myxovirus (influenza virus) resistance 1 (MxA),
2V5V-oligoadenylate synthetase 2 (OAS2), ISG56 and cig5.
Immunoblot analyses were performed to correlate increased
mRNA expression with elevated protein levels. The association
between ISG expression and JCVinfection has not been reported
previously. Thus, to further validate that the antiviral response
was specific to JCV infection, altered expression of key ISG was
analyzed in JCV-infected PHFG and U87MG glioblastoma cells
at different time points by real-time RT-PCR.
Results
JCV DNA replication and transcription following transfection
of PHFG cells
Three PHFG cell cultures derived from independent biologi-
cal specimens were transfected with infectious JCV(Mad1)DNA. Thirty seven percent of PHFG cells transfected with
pcDNA3.1/CT-GFP expressed GFP at 48 h post-transfection
as measured by flow cytometry (data not shown). The
efficiency and success of transfections were further con-
firmed using DNA replication and RT-PCR-based assays.
The profiles of JCV DNA replication following transfection,
as determined by Southern blotting, showed low levels at
day 5 and significantly higher levels at days 10 and 15
(Fig. 1A). All three biological specimens produced similar
results.
The mRNAs coding for T antigen and agnoprotein or VP1
were detected by RT-PCR at 3 and 5 days post-transfection,
respectively, and the amounts of viral transcripts increased
steadily over 15 days (Fig. 1B). JCVDNA replication is initiated
upon expression of T antigen; replication is detectable as a faint
band on Southern blots by day 5 post-transfection (Fig. 1A). The
temporal difference in the detection of T antigen mRNA and
JCV DNA replication is due to differences in the sensitivity of
the two assays. Therefore, gene expression profiles of mock- and
JCV-transfected PHFG cells were compared on day 10 following
transfection using microarray chip analysis.
Microarray analysis of PHFG cells after JCV transfection
Total RNA samples were prepared from the JCV- and mock-
transfected PHFG cells on day 10 at a time when early and late
viral transcription are active (Fig. 1) and detectable secondaryt
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S. Verma et al. / Virology 345 (2006) 457–467 459infection has not yet occurred (Walker and Frisque, 1986).
Gene expression profiles were determined using Affymetrix
U133A chips that include oligonucleotides corresponding to
14,500 human genes. For analysis, target RNA preparations of
JCV-transfected cells were compared with mock-transfected
cells used as baseline. Differential expression of 410 genes was
observed, of which 265 genes were up-regulated, and 145
genes were down-regulated. Genes, whose expression levels
changed 2-fold or more, either up or down, were identified for
further analysis.
Our data demonstrate an increase in the levels of expression
(>2-fold) of 51 cellular genes that encode proteins involved in
cell cycle regulation, cell growth, transcriptional activation, cell
communication and signal transduction (Table 1). Importantly,
we observed a profound up-regulation of several ISG. At least
15 of the 51 genes that exhibited a 2-fold or greater increase in
expression were IFN-responsive genes, including MxA, OAS2,
STAT1, cig5, and ISG56 (Table 1). Interferons bind to their
cognate receptors and initiate a signaling cascade that involves
the STAT family of transcription factors. STAT1, a component
of IFN-stimulated gene factor 3 (ISGF3) (Fu et al., 1990), that
binds and activates interferon-stimulated response elements
(ISRE) was induced 3-fold during JCV replication. Upon
activation by phosphorylation, STAT1 forms hetero- or homo-
dimers, translocates to the nucleus and induces production of
many proteins including MxA, OAS2/3, ISG56 (also known as
IFIT1) and IFI6–16, via binding to ISRE (Darnell et al., 1994).
Transcripts of a few genes associated with cell cycle
regulation/communication, such as the cyclin D2 (2-fold),
cyclin E (1.8-fold), transforming growth factor-h (TGF-h)
(1.8-fold) and TGF-h receptor1 (TGF-hR1) (2-fold), which
have been predicted to influence JCV–host interactions
(Radhakrishnan et al., 2003), were up-regulated. Finally, no
obvious biological patterns of genes suppressed by JCV could
be identified.
Real-time RT-PCR analysis of ISG and TGF-b after JCV
transfection
To extend findings obtained in the microarray experiments,
expression of nine genes whose fold change ranged from very
high, low, and no change (NC) was examined by real-time RT-
PCR on three independent preparations of PHFG cells trans-
fected with JCV DNA (Table 2). GAPDH, which was not
significantly regulated in JCV-transfected cells as noted in the
microarray experiments, was used as a reference gene for
normalization in parallel with the gene of interest. The induction
of each gene was expressed as a relative fold induction in
comparison to the control. The amplification plot of the PCR
data was used to determine the threshold cycle (CT) (Pfaffl,
2001). The results for all genes tested concurred with the
microarray data and revealed a high consistency between the
three RNA preparations from the independent biological speci-
mens. However, we observed some differences in the level of
induction measured by the RT-PCR and microarray assays. For
example, the fold induction for cig5 and MxA gene expression
was 3 to 7 times higher when measured by real-time RT-PCR vs.microarray assay. Since our microarray results demonstrated
increase in the expression of two members of the P56 family,
ISG56 and ISG60, which are highly induced by IFN, dsRNA
and many viruses, we conducted real-time analysis of ISG56.
Our data indicated substantial induction of the mRNA transcript
of ISG56 gene in all three JCV-transfected PHFG cell prepara-
tions. Interferon regulatory factors (IRF) such as IRF3 and IRF7
are critical components of the transcription complexes that
recognize the IFN-stimulated response element (ISRE). JCV
replication did not alter the level of IRF3 transcript in either
microarray or real-time experiments, while IRF7 was increased
by two-fold. However, IFI44, which is one of the prominent
genes induced by activated IRF3, was increased using micro-
array (37.8-fold), and real time RT-PCR (5.3-fold). In addition,
we observed a slight up-regulation (1.5 to 1.8-fold) of TGF-h
using both techniques at day 10 after JCV transfection.
Evaluation of cellular MxA and cig5 protein expression in
transfected cells
To corroborate that the induced transcription of cellular
genes is manifested at the protein level, we conducted Western
immunoblot analysis of the cellular MxA and cig5 proteins as
examples of up-regulated IFN-inducible genes. PHFG cells
transfected with pcDNA3.1-GFP were used as an additional
control to rule out the possibility that induction of these genes
was due to the introduction of a foreign DNA. MxA and cig5
protein profiles were examined at four time points following
transfection (Fig. 2). At day 3 post-transfection, MxA protein
levels were low and close to the basal level in mock-transfected
cells. The amount of MxA protein increased significantly by
day 5 post-transfection and then decreased slightly on days 10
and 15 post-transfection; the levels were higher at each of these
time points than in the mock- and GFP-transfected PHFG cells.
The highest level of cig5 protein was observed early after
transfection and was considerably higher as compared to the
two controls (Fig. 2). The amounts of h-actin protein remained
constant at all time points.
Expression of ISG is induced in JCV-infected PHFG and
U87MG cells
The products of ISG are induced in response to virus
infection and act on infected as well as uninfected cells to
activate a global antiviral state. Since our microarray data
identified interferon-inducible genes as the subset of genes
most influenced following JCV transfection, we asked whether
similar cellular gene activation occurred during a viral
infection. Studies performed in our laboratory demonstrate
that the U87MG glioblastoma cell line supports JCV replica-
tion and transcription leading to infectious virion production
(P. Ananthula et. al., unpublished observation). It has been
proposed that U87MG cells are a convenient and alternative
cell culture system for PHFG cells for studying JCV
pathogenesis. Real-time RT-PCR analysis of four ISG (STAT1,
ISG56, cig5 and MxA) was performed at different time points
on RNA extracted from JCV-infected U87MG and PHFG cells
Table 1
Profile of differentially expressed genes
Gene name or product Gene ID Probe set ID GenBank accession no. Fold change
Interferon-inducible genes
Interferon-induced protein 44 IFI44 214059_at BE049439 37.8
Interferon, alpha-inducible protein 27 IFI27 202411_at NM_005532 16.5
2V,5V-oligoadenylate synthetase 1, 40/46 kDa OAS1 202869_at NM_016816 10.8
Myxovirus (influenza virus) resistance 1 MX1 202086_at NM_002462 8.3
Viperin cig5 213797_at AI337069 7.3
Interferon, alpha-inducible protein (clone IFI-15K) ISG15 205483_s_at NM_005101 6.5
Interferon-induced protein with tetratricopeptide repeats 1 IFIT1/ISG56 203153_at NM_001548 6.3
Interferon-induced transmembrane protein 1 IFITM1 214022_s_at AA749101 4.4
Interferon-induced protein with tetratricopeptide repeats 4 IFIT4/ISG60 204747_at NM_001549 3.2
Interferon, alpha-inducible protein (clone IFI6–16) G1P3 204415_at NM_022873 3.0
Signal transducer and activator of transcription 1, 91 kDa STAT1 209969_s_at BC002704 3.0
2V,5V-oligoadenylate synthetase 2, 69/71 kDa OAS2 204972_at NM_016817 2.6
2V,5V-oligoadenylate synthetase 3, 100 kDa OAS3 218400_at NM_006187 2.6
Interferon regulatory factor 7 IRF7 208436_s_at NM_004030 2.0
Interferon-induced with helicase C domain 1 IFIH1 219209_at NM_022168 2.0
Cell growth, cell cycle and cell proliferation genes
Bone marrow stromal cell antigen 2 BST2 201641_at NM_004335 5.7
Alpha1 adrenergic receptor ADRA1A 211489_at D32201 4.3
Nuclear cap bindin protein subunit 1, 80 kDa NCBP1 209519_at BG108193 3.6
Cyclin D2 CCND2 200952_s_at AI635187 2.0
Solute carrier family 4, sodium bicarbonate cotransporter SLC4A7 210286_s_at AF053755 2.0
Epithelial membrane protein 3 EMP3 203729_at NM_001425 2.0
Microtubule-associated protein, RP/EB family, member 3 MAPRE3 214270_s_at AI885178 2.0
Tumor protein p53 (Li-Fraumeni syndrome) TP53 211300_s_at K03199 2.0
Transcription factors
ZFX mRNA for transcription activator, isoform 3 ZFX 217176_s_at X59740 2.2
Zinc finger protein 426 ZNF426 205964_at NM_024106 2.1
SP110 nuclear body protein SP110 209761_s_at AA969194 2.0
Zinc finger protein, transcription factor 8 TCF8 210875_s_at U12170 2.0
Zinc finger protein ZNF286 (ZNF286) ZNF286 220250_at NM_020652 2.0
Cell communication/signal transduction
Similar to islet cell autoantigen ICA1 211740_at BC005922 4.1
Integrin, beta 8 ITGB8 205816_at NM_002214 2.8
Alpha1 adrenergic receptor ADRA1A 211489_at D32201 2.8
Lectin, galactoside binding LGALS8 210731_s_at AL136105 2.4
Protein kinase C, iota PRKCI 209677_at L18964 2.0
Transforming growth factor, beta receptor I TGFBR1 206943_at NM_004612 2.0
Miscellaneous
N-myristoyltransferase 1 NMT1 201158_at AI570834 6.2
Hypothetical protein FLJ20035 FLJ20035 218986_s_at NM_017631 6.1
Macrophage stimulating 1 hepatic growth factor-like MST1 213382_at AL137798 3.5
KIAA0117 gene KIAA0117 214942_at D38491 3.1
Hect domain and RLD 6 HERC6 219352_at NM_017912 3.0
Programmed cell death 4 PDCD4 202730_s_at NM_014456 2.8
Cytochrome P450, subfamily 1 CYP1A2 207608_x_at NM_000761 2.8
Cytochrome P450, subfamily XIB CYP11B1 214610_at AV702430 2.7
DC31 mRNA _ 209483_s_at AF255793 2.7
Lysosome associated membrane glycoprotein LAMP1 201551_s_at J03263 2.5
Family with sequence similarity 46, member A FAM46A 221766_s_at AW24667 2.4
Early endosome antigen 1, 162 kDa (EEA1) EEA1 204841_s_at NM_003566 2.1
Hypothetical protein FLJ21168 FLJ21168 204666_s_at NM_0250 2.1
Mn containing superoxide dismutase SOD2 216841_s_at X15132 2.0
Phospholipid scramblase 1 PLSCR1 202430_s_at NM_021105 2.0
Mammalian LIN-7 protein 3 LIN7C 219399_at NM_018362 2.0
HLA class I heavy chain HLA-A 211799_x_at U62824 2.0
Down-regulated genes
Phorbol-12-myristate-13-acetate-induced protein 1 PMAIP1 204285_s_at AI857639 4.3
CGI-146 protein PNAS-4 222158_s_at AF229834 3.2
Yippee-like 1 YPEL1 213996_at NM_013313 3.0
Williams Beuren syndrome chromosome region 20C WBSCR20C 213670_x_at AI768378 3.0
Ribosomal protein S11 RPS11 213350_at BF680255 2.7
Immunoglobulin superfamily, member 4C IGSF4C 215259_s_at AC005525 2.6
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Down-regulated genes
Protein phosphatase 1, regulatory (inhibitor) subunit 12A PPP1R12A 201602_s_at BE737620 2.6
Secreted frizzled-related protein 1 SFRP1 202036_s_at AF017987 2.5
Twist homolog TWIST 213943_at X99268 2.4
Potassium channel tetramerization domain containing 12 KCTD12 212188_at AA551075 2.2
H3 histone, family 3A H3F3A 213826_s_at AA292281 2.0
Nuclear pore complex interacting protein NPIP 204538_x_at NM_006985 2.0
Cytoskeleton-associated protein 4 CKAP4 200998_s_at AW029619 2.0
Table 1 (continued)
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and 50 HAU of JCV led to a 2- to 12-fold increase in the levels
of STAT1, ISG56, cig5 and MxA transcripts at days 8 and 14
post-infection. Increasing the multiplicity of infection 10-fold
(500 HAU) enhanced the up-regulation of these same genes in
U87MG cells by approximately 1 to 2 orders of magnitude. A
sharp increase in the STAT1, ISG56, cig5 and MxA transcripts
between days 5 and 8 post-infection, correlating with the rapid
increase in copies of JCV genomes determined by real-time
PCR (Table 3), was noted. As determined by real-time RT-
PCR, the expression of IFN-a and IFN-h in JCV-transfected
PHFG cells (Table 2), and in JCV-infected PHFG and U87MG
cells (data not shown), did not change significantly.
Discussion
JCV, an opportunistic pathogen, lytically infects oligoden-
drocytes and causes the progressive neurodegenerative disease,
PML. In PML patients, JCV primarily targets oligodendrocytes,
although a few reports suggest that JCV infects astrocytes and
granule cell neurons (Du Pasquier et al., 2003; Enam et al.,
2004; Richardson-Burns et al., 2002; von Einsiedel et al., 2004).
In vitro, PHFG cells mimic the in vivo tissue milieu, in which
both oligodendrocytes and astrocytes support efficient JCV
replication. We therefore chose to transfect this oligodendro-
cyte-rich heterogeneous population of glial cells with an
infectious molecular clone of JCV(Mad1) to study the impact
of viral replication on host gene expression. Differential
expression of 410 genes was observed on day 10 post-
transfection, of which 265 genes were up-regulated and 145Table 2
Microarray and real-time RT-PCR analysis of IFN-inducible genes and TGF-h
in JCV-transfected cells
Gene GenBank no. Relative change in the level of expressiona
Microarray Real-time RT-PCR
Mean Range
cig5 AI337069 7.3 50.9 33–68
STAT1 BC002704 3 4.13 3.1–6
MxA NM_002462 8.3 27.8 17–38
IFIT1 (ISG56) NM_001548 6.3 7.9 1.8–27
IFI44 BE049439 37.8 5.3 2.2–10.6
IRF3 NM_001571 NC NC 0.3–0.6
TGF-h BF061658 1.8 1.51 1.4–2.2
IFN-a NM_002176 NC NC 0.1–0.8
IFN-h BC093757 NC NC 0
NC, no change.
a Compared to mock-transfected cells.genes were down-regulated. Surprisingly, there were no genes
among the down-regulated genes that are repressed more than
4.3-fold, and no easily discernible families could be identified
(Table 1). However, among the up-regulated genes, 51 genes
were induced 2-fold or more, most notable being antiviral
defense response genes, including several interferon responsive
genes. These latter findings have not been reported previously.
Efficient production of IFN is an essential component of the
host’s defense against virus invasion, and the binding of IFN to
cell surface receptors results in the induction of a set of ISG that
mediate antiviral action (Darnell et al., 1994). Recent evidence
suggests that many ISG are also induced by dsRNA or by other
viral products in the absence of IFN. Sarkar and Sen have
recently used the term ‘‘viral stress-inducible genes’’ (VSIG) to
describe a set of genes induced by three independent mechan-
isms: virus infection, IFN and dsRNA (Sarkar and Sen, 2004).
Initially, it was thought that induction of these genes by viruses
or dsRNA was a consequence of IFN production. However, it
has been unequivocally established that these genes can be
induced independent of IFN (Bandyopadhyay et al., 1995; Daly
and Reich, 1993; Sarkar and Sen, 2004). In naive cells, the basal
level of VSIG is very low, but they are strongly induced
transiently upon exposure to viral stress. In our experimental
system, the up-regulated ISG, such as STAT1, OAS, MxA and
ISG56, belong to the VSIG family. Among these, STAT1, which
was up-regulated three-fold in our experimental system, is theFig. 2. Western blot analysis of MxA, cig5 and h-actin in JCV-transfected
PHFG cells. Western blot analysis was performed on protein extracts from
mock, pcDNA3.1/GFP and JCV-transfected cells harvested on days 3, 5, 10
and 15. Forty micrograms of protein from whole cell extracts were separated by
SDS-polyacrylamide gel electrophoresis and transferred to a nitrocellulose
membrane. Membranes were incubated with mouse monoclonal anti-MxA
(1:1000 dilution, gift from Dr. Otto Haller), rabbit polyclonal anti-cig5 (1:1000
dilution, gift from Dr. Keh-Chuang Chin) and mouse anti human-h-actin
(1:1000 dilution, Sigma). Bands were visualized following incubation with
alkaline-phosphatase-conjugated secondary antibodies (Bio-Rad) for MxA and
h-actin and horseradish-peroxidase-conjugated secondary antibody (Amersham
Biosciences) for cig5 following the manufacturers’ instructions. h-actin was
used as an internal control.
Table 3
JCV copy numbers and fold induction of IFN-inducible genes at different time points in JCV-infected cells
Cells/HAU Gene-Fold
inductiona
JCV
copies/mLb
Days after infection with JCV
Day 3 Day 5 Day 8 Day 14
Copy numbers 4.7  106 2.6  107 1.0  108 5.9  108
U87MG/10HAU MxA NC 1.1 1.4 3
STAT1 1.5 2.1 5.5 5.4
cig5 1.8 4.6 9.15 12.2
ISG56 2.9 1.3 4 4.6
Copy numbers 2.7  108 3.3  108 2.7  109 3.4  109
U87MG/500HAU MxA 1.1 1.7 233 378
STAT1 7.1 12.5 541 552
cig5 46 51.1 3326 3962
ISG56 3.2 3.1 26.3 33.2
Copy numbers 9.4  106 1.0  107 1.2  108 1.0  109
PHFG/10HAU MxA NC NC 1.2 2.1
STAT1 NC NC NC 3
cig5 0.5 0.9 4 4.2
ISG56 NC NC NC 2.3
Copy numbers 5.5  106 8.8  107 2.8  108 4.4  109
PHFG/50HAU MxA 0.4 0.6 2.1 11.5
STAT1 1.3 1 2 2.6
cig5 1.4 1 3 10.5
ISG56 1.5 1.8 2.1 3.6
NC, no change; HAU, hemagglutination unit.
a Real-time RT-PCR was performed.
b Real-time PCR was performed.
S. Verma et al. / Virology 345 (2006) 457–467462principal regulator of the IFN response pathway. Genes, such as
MxA, OAS1, OAS2 and ISG56K, have STAT1-binding
elements in their promoters and are regulated by STAT
activation. MxA protein, which was significantly increased in
JCV-transfected PHFG cells, is a dynamin superfamily GTPase
that interferes with viral replication (Frese et al., 1996; Kochs
and Haller, 1999a, 1999b). The 2V5V OAS proteins activate
RNase L and lead to the degradation of viral mRNAs (Floyd-
Smith et al., 1981). ISG56, which belongs to the P56 family of
proteins, is one of the most highly induced genes in response to
IFN, dsRNA and many viruses. P56 family member contains
multiple tetratricopeptides motifs, which bind to eIF-3. This
interaction causes impairment of eIF-3 and results in inhibition
of viral protein synthesis.
Our data also demonstrate for the first time the induction of a
unique IFN-inducible gene, cig5 or viperin, following JCV
replication in human cells. First reported by Chin and
Cresswell, this antiviral protein is expressed in response to
human cytomegalovirus (HCMV) infection, and its envelope
protein glycoprotein B is shown to inhibit viral replication
(Chin and Cresswell, 2001). HCMV, a member of herpesvirus
group, and JCV are structurally unrelated but share some
epidemiological and pathogenetic features, such as high
prevalence in the human population, latency in kidney and
asymptomatic primary infection in childhood. Impaired immu-
nocompetence results in the reactivation of these viruses leading
to severe life-threatening nervous system complications.
Cellular IFN regulatory factors, IRF3 and IRF7, are a family
of transcriptional regulators and are important in the context of
viral induction of IFN genes and ISG. IRF3, a key transcrip-
tional activator, is a subunit of dsRNA-activated transcription
factor complex (DRAF) (Lin et al., 1999). It is directly activatedby dsRNA or by virus infection, translocates to the nucleus,
binds to the transcriptional co-activator p300/CAB and con-
tributes to the activation of IFN a/h responsive genes
(Bandyopadhyay et al., 1995; Daly and Reich, 1993; Hummer
et al., 2001). Though our data do not show direct induction of
IRF3, many of the genes induced by IRF3 such as ISG56,
ISG60, OAS and cig5 (Grandvaux et al., 2002) are up-regulated
in the presence of JCV. Similar to IRF3, IRF7, which is up-
regulated by 2-fold in our experimental system, is a critical
determinant for induction of the IFN genes and functions in part
by a positive feedback mechanism (Marie et al., 1998).
We infected PHFG and U87MG cells with JCV virions to
ensure that alterations to the expression of ISG were not non-
specific events caused by transfection of cells with JCV DNA.
Induction of STAT1, ISG56, cig5 and MxA genes by JCV in
both cell types following infection confirms that this response is
specifically mediated by JCV. Moreover, induction of antiviral
genes was dose-dependent, with the expression levels of four
genes being elevated 10- to 100-fold when the viral inoculum
was increased from 10 to 500 HAU per plate of cells. It may
only reflect the cumulative response of a larger number of
infected cells by 500 HAU. The higher dose of infection did not
alter the time at which this slowly replicating virus underwent a
rapid increase in DNA replication in either primary or
immortalized cells. The approximate 5- to 10-fold increase in
JCV copy number at day 8 post-infection corresponded to the
increase in antiviral response (Table 3). This dramatic increase
in ISG expression may only reflect the cumulative response of a
larger number of infected cells by 500 HAU of JCV.
As there is no significant change in the transcripts of IFN-a
and IFN-h in both transfected and infected cells, the induction
of ISG as observed in our data is likely to be an IFN-
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signaling cascade could be the activation of ISG by virus-
specific dsRNA. There are several stages during the replication
cycle of JCV when dsRNA could occur as an intermediate
product of transcription. The genome of JCV is divided into
early and late transcription units, with the early genes and late
genes being transcribed from opposite DNA strands in opposite
directions (Frisque et al., 1984). This arrangement has been
shown in mouse polyomavirus and SV40 to lead to greater than
genome-length transcripts, having the potential to form dsRNA
molecules (Hersh et al., 1984; Kumar and Carmichael, 1997).
Currently, it is unknown whether such dsRNAs form in cells
infected with JCV.
Several viruses target the IFN signaling system and elicit
immune responses during infection. The induction is more
pronounced in RNA viruses, like Hantaan virus, human
parainfluenza virus and Rous sarcoma virus (Garcia-Sastre et
al., 1998; Kong et al., 2003; Nam et al., 2003). Most DNA
viruses, such as adenoviruses and human papillomavirus, use
multiple mechanisms to debilitate STAT-mediated antiviral
responses that are presumed to help evade host immune
surveillance. Nevertheless, the JCV-induced response de-
scribed in this report is very similar to that induced by several
herpesviruses, such as Epstein–Barr virus, herpes simplex
virus, Kaposi’s sarcoma-associated herpesvirus and HCMV. All
of these viruses activate IFN-responsive genes, such as MxA,
OAS and IFI 6–16 (Browne et al., 2001; Mossman et al., 2001;
Poole et al., 2002; Ruvolo et al., 2003; Zhu et al., 1998). The
effect of the accumulation of these antiviral products on JCV
replication is not clear at this point. However, it may be
possible that these gene products collectively contribute to
restricting JCV growth initially and slowing down spread of the
virus to neighboring cells in healthy immunocompetent hosts.
JCV might employ this strategy to develop a long-term
association with the host.
A recent study examined JCV’s effects on cellular gene
expression using microarray analysis of RNAs extracted from
human fetal astrocyte cultures 15 days following infection with
the JCV-SV40 chimera, Mad1/SVEdelta (Radhakrishnan et al.,
2003). This chimeric virus consists of JCV coding region
sequences and a hybrid JCV-SV40 promoter–enhancer. Ex-
pression of several cellular genes was reported to be up-
regulated, including those involved in cell cycle regulation
(Radhakrishnan et al., 2003). We also found enhanced
transcription of cell cycle regulatory genes, supporting the
hypothesis that JCV promotes cell cycle progression to
facilitate viral DNA replication (Radhakrishnan et al., 2003).
Strikingly, Radhakrishnan et al. (2003) did not report the up-
regulation of any IFN-inducible genes identified in the current
study, suggesting that differences in the cell culture system and
virus employed greatly influence the outcome of such
experiments.
In conclusion, our studies represent a starting point for the
analysis of links between JCV and cellular defense responses.
Our microarray results identify novel genes altered by the
JCV–host interaction. Enhanced production of proteins
encoded by ISG in response to JCV infection would beexpected to induce an antiviral state. Although this response is
not sufficient to block virus replication, it may modulate the
infection and limit spread of JCV from cell to cell, thereby
explaining the slow replication and subtle cytopathogenic
effects of JCV-infected PHFG cells. Deciphering the molecular
mechanisms, by which JCV induces changes in cellular gene
expression, will enhance our understanding of the basic
biology of the virus–host interaction and ultimately aid in
elucidating the pathogenesis of PML.
Materials and methods
Cell culture
PHFG cells were obtained from therapeutically aborted 10-
to 14-week-old fetuses from the Kapiolani Medical Center for
Women and Children (KMCWC) in Honolulu, Hawai’i, and
from the University of Washington, after receiving approval
from the KMCWC institutional review board. Fetal tissues
were processed, and cells were maintained as described
previously (Swenson et al., 1996). The human glioblastoma
cell line (U87MG) was obtained from the American Type
Culture Collection (Rockville, MD) and propagated in Eagle’s
Minimum Essential Medium (EMEM) containing 10% FBS
and 1% penicillin and streptomycin.
JCV transfection and infection
Oligodendrocyte-rich PHFG cell cultures, prepared from
three different biological specimens, were transfected using
Lipofectine, a lipid-based transfection reagent (Invitrogen,
Carlsbad, CA) according to the manufacturer’s protocol.
Briefly, PHFG cells were grown to 60–70% confluency in
35-mm or 100-mm plates. The cells were washed twice with
Opti-MEM medium (Gibco, Grand Island, NY) and transfected
with circular full-length JCV(Mad1) DNA devoid of vector
sequences. Viral DNA, 0.1 or 1 Ag, was added to 35-mm or
100-mm plates, respectively, and incubated for 6 h at 37 -C.
For control experiments, transfections were conducted with
Lipofectine alone, without DNA. To determine the transfection
efficiency at 48 h, PHFG cells were transfected with the GFP
plasmid pcDNA3.1/CT-GFP (Invitrogen), and the percentage
of fluorescent cells was measured by flow cytometry.
For infection experiments, PHFG and U87MG glioblastoma
(5  105) cells were seeded on 35-mm plates grown to 60–
70% confluency and infected with 10, 50 or 500 hemagglu-
tinating units (HAU) of prototype JCV(Mad1) for 3 h and
washed three times with their respective serum-free culture
medium. Cells were maintained for the duration of the
experiment in their respective culture medium supplemented
with serum.
Southern blot analysis
Cells were harvested on days 3, 5, 10 and 15 following
transfection, and total genomic DNA was extracted with the
DNAeasyi tissue kit (Qiagen, Valencia, CA) (Ziegler et al.,
Fig. 3. Purity and integrity of RNA extracted on day 10 from mock (A)- and
JCV (B)-transfected PHFG cells. The ratios of 28S/18S RNAwere 1.75 and 1.8
for mock- and JCV-transfected cells, respectively. (C) Scatter plot demonstrat
ing the variation in fluorescent signal intensities between mock- and JCV
transfected PHFG cells. Each dot represents the signal for one gene. Changes in
2-, 3-, 10- and 30-fold are highlighted by parallel lines flanking the cente
diagonal line.
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precipitated and suspended in 10 AL 1 TE. DpnI selectively
digests transfected plasmid DNA, which is methylated during
prokaryotic replication; DNA replicated in PHFG cells is
resistant to DpnI cleavage. Digested DNAwas electrophoresed
on a 0.8% agarose gel and blotted onto nylon membranes
(Schleicher and Schuell, Keene, NH). Membranes were UV
cross-linked and hybridized with 32P-labeled linear full-length
JCV DNA.
RNA extraction
Cells were washed twice with PBS and lysed directly on the
plates with lysis buffer (RNeasy Mini Total RNA Isolation Kit,
Qiagen Inc.). Total RNA was extracted from lysates of
transfected and infected cells, in duplicate, on days 3, 5, 10
and 15 following transfection using the RNAeasy kit according
to the manufacturer’s protocol (Qiagen Inc.). Genomic DNA
contamination was eliminated by digesting the RNA with
RNase-free DNase (Ambion, Austin, TX). The yield and purity
of each RNA sample were determined by using an Agilent
2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA).
The 28S/18S RNA ratios of all RNA specimens as determined
by the Bioanalyzer were between 1.6 and 2.
Microarray analysis
Biotinylated cRNA targets were prepared from 10 Ag
aliquots of the total RNA extracted from JCV-transfected
PHFG cells at day 10 following the Affymetrix protocol.
Briefly, total RNAwas reverse transcribed to first-strand cDNA
using Superscript II reverse transcriptase (Invitrogen) promoted
by T7-(dT)24 oligomer, and second-strand synthesis was
performed using T4 DNA polymerase. cDNA was transcribed
in vitro and labeled using biotin-UTP and biotin-CTP to
produce biotin-labeled cRNA (Bioarray High Yield RNA
transcript labeling kit, ENZO, Farmingdale, NY). cRNA target
integrity was determined with an Affymetrix Test 3 array, which
contains probe sets representing a subset of characterized genes
from various organisms, including housekeeping genes of
mammals, plants and eubacteria. Prehybridization to GeneChip
Test 3 array was performed to determine the quality of the
labeled target prior to its analysis using the Affymetrix U133A
chip. These arrays contain cDNA oligomers that are comple-
mentary to 18,400 transcripts and variants, including 14,500
well-characterized human genes (Affymetrix, Santa Clara, CA).
Hybridization was conducted for 16 h at 45 -C with rotation at
60 rpm. Four prokaryotic genes (bioB, bioC, bioD and cre) were
added to the hybridization cocktail as internal controls. Gene
chip arrays were scanned at 570 nm with a gene array scanner
and analyzed with Microarray Analysis Suite 5.0 software and
Data Mining Tool (Affymetrix). For comparison of fluorescence
intensity (average difference) values among JCV- and mock-
transfected chips, the average difference values for each JCV-
transfected gene chip were normalized to that of the mock-
transfected chip and the change in expression levels was
calculated (Fig. 3). A gene was considered up- or down--
-
rregulated if its expression increased or decreased by 2-fold or
more compared to the mock-transfected cells.
Real-time RT-PCR for cellular genes
RNA samples from all three batches of transfected PHFG
cells, including those analyzed by microarray, and from infected
PHFG and U87MG cells, were assayed by real-time RT-PCR
using SYBR Green (Bio-Rad iCycler, Hercules, CA) to confirm
changes in the expression of selected genes. Total RNA from
each sample (1 Ag) was denatured in the presence of random
primers at 65 -C for 10min and thereafter chilled on ice. Amaster
mix of first-strand buffer, 0.1 M DTT, 40 U of recombinant
ribonuclease inhibitor and 25 U of Superscript II reverse
transcriptase (Invitrogen), was added to the tube and incubated
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incubation at 70 -C for 15 min. Real-time RT-PCR was
performed on 2 AL of diluted cDNA in duplicate with both
internal and no template controls. Primer sequences used for
amplification of cig5, STAT1,MxA, interferon-inducible protein
56 (ISG56), interferon regulatory factor (IRF3), IFI44, IFN-a
and IFN-h genes were designed using the Beacon Designer 2.0
(PREMIER Biosoft International, Palo Alto, CA) primer design
software (Table 4). The housekeeping gene GAPDHwas used as
an internal control for normalization in parallel with each gene of
interest. PCR cycling conditions were 95 -C for 5 min, 36–38
cycles of 95 -C for 10 s, 57 -C for 10 s and 72 -C for 15 s, and the
melt curve starting from 60 -C to 90 -C. Each reaction was
performed at least three times, with duplicate samples, to verify
reproducibility. PCR product intensity data were normalized
relative to GAPDH, and the relative fold change was calculated
using the Pfaffl method (Pfaffl, 2001).
Real-time PCR for JCV copy number
JCV DNA amplification and quantitation were performed in
the Bio-Rad iCycler iQ Multicolor Real-time PCR Detection
System using 1 AL of template DNA, Bio-Rad 2 iQi
SYBERR Green supermix and 12.5 pmol each of forward and
reverse primers specific for JCV T antigen gene (Table 4) in a
final reaction volume of 20 AL. Thermal cycling was initiated
with a first denaturation step of 10 min at 95 -C followed by 35
cycles of 95 -C for 10 s and 62 -C for 10 s, and theTable 4
Primers employed for amplification of IFN-inducible, JCV and GAPDH genes
Gene Sequence Amplicon size
T-antigen F CTC AGG TAG GCC TTT GGT CTA AA 350 bpa
R GCT ATT CAA GGG GCC AAT AGA C
F AGA GTG TTG GGA TCC TGT GTT TT 90 bpb
R GAG AAG TGG GAT GAA GAC CTG TTT
Agno F GGA TTT TTG CAC AGG TGA AGA C 90 bpa
R TGG TTC AGG CAA AGC ACT GTA
VP1 F CAT GAC AAT GGT GCA GGA AAG CC 185 bpa
R CGC CTT GTG CTC TGT GTT CAT TAC
GAPDH F AGT TAG CCG CAT CTT CTT TTG C 100 bpa
R CAA TAC GAC CAA ATC CGT TGA CT
cig5 F TGG TGA GGT TCT GCA AAG TAG A 126 bpc
R TCA CAG GAG ATA GCG AGA ATG TC
STAT1 F TGC TCC TTT GGT TGA ATC CCC 92 bpc
R GGA ATT TTG AGT CAA GCT GCT GA
MxA F AGT ATG GTG TCG ACA TAC CGG A 145 bpc
R GAG TCT GGT AAA CAG CCG AAT G
ISG56 F CTTGAGCCTCCTTGGGTTCG 137 bpc
R GCTGATATCTGGGTGCCTAAGG
IFI44 F AAG GGC ATG TAA CGC ATC AGG 151 bpc
R CCG CCT TCT TTC TCA CTC AGC
IRF3 F GAC GCT CAC CAC GCT ATG 171 bpc
R GCA GGT CCA CAG TAT TCT CC
IFN-a F CTC CTT TCT CCT GCC TGA AG 170 bpc
R AAG TGT CTC ATC CCA AGT AGC
IFN-h F CTC TCC TGT TGT GCT TCT CC 152 bpc
R GTC AAA GTT CAT CCT GTC CTT G
a RT-PCR primers for amplification of JCV and GAPDH genes.
b Real-time PCR primers to determine JCV copy numbers.
c Real-time RT-PCR primers to amplify IFN-inducible genes.amplification fluorescence was read at 60 -C. A standard curve
for the quantification of JCV DNAwas constructed using serial
dilutions of a plasmid containing the entire linear genome of
JCV(Mad1). Dynamic range of detection was determined by
preparing 10-fold serial dilutions of JCV DNA in the range of
100 pg to 10 fg that represented 1.8  109 to 1.8  105 copies
of JCV DNA, respectively. All experiments were performed at
least twice, and samples were run in triplicate each time. The
amounts of JCV DNA in experimental samples were calculated
from the standard curve and were expressed as copies of viral
DNA per mL of total DNA.
RT-PCR for JC viral genes
cDNA was synthesized from RNA extracted from JCV-
transfected and JCV-infected cultures at various time points
using the aforementioned protocol. One microgram of RNAwas
used for cDNA synthesis, and 1 AL of cDNA was used for
amplification of JCV T antigen, agnoprotein and VP1 genes
(primer sequences in Table 4) in a GeneAmp Thermal Cycler
9700 (Perkin-Elmer, Wellesley, MA). The GAPDH gene was
amplified as a control with each RT-PCR. The cycling conditions
were 95 -C for 5 min, 95 -C for 15 s, 57 -C for 15 s and 72 -C for
20 s (28 cycles) and a final extension step at 72 -C for 5 min. The
amplicons were electrophoresed on a 2% agarose gel, and the
ethidium bromide fluorescence was visualized after scanning
with a Bio-Rad Molecular Phosphorimager.
Western immunoblots for detection of cellular proteins
Total cellular protein extracts were prepared from mock- and
JCV-transfected PHFG cells. Cells were washed with cold PBS
and lysed with 250 AL NP40 lysis buffer, consisting of 20 mM
Tris pH 7.5, 120 mM NaCl, 1% NP-40, 1 mM EDTA, 1 mM
DTT, 10 mMNaF, 2mM sodium vanadate, 1 mMPMSF and 1%
protease inhibitor cocktail (Sigma catalog number P8340). Total
protein was separated by centrifuging the lysates for 10 min at
14,000 rpm. Protein concentration was assayed using the
Bradford technique (Bio-Rad), and 40 Ag of protein extracts
was boiled in Laemmli buffer for 10 min and fractionated on
10% SDS-polyacrylamide gels. Proteins were transferred by
electro-blotting onto nitrocellulose filters (Bio-Rad) and blocked
for 2 h in TBS plus 0.3% Tween and 5% BSA.
Filters were incubated with primary antibody for 2 h at room
temperature in the blocking solution. The immunoblots were
washed in TBS with 0.5% Tween (TTBS) three times for 15
min each and incubated with the appropriate secondary
antibody in the blocking solution (5% BSA) for 1 h followed
by three washes with TTBS. The bound goat alkaline-
phosphatase-conjugated anti-mouse secondary antibody was
detected using a color development kit (Bio-Rad), and donkey
HRP-conjugated anti-rabbit secondary antibody was devel-
oped, using enhanced chemiluminescence (Amersham Bios-
ciences, Piscataway, NJ). Primary antibodies included mouse
anti-human h-actin (Sigma), mouse monoclonal anti-MxA (gift
from Dr. O. Haller) and rabbit polyclonal anti-cig5 (gift from
Dr. K.-C. Chin).
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